Why is Infinium Pharma falling/rising?

As of 12-Aug, Infinium Pharmachem Ltd is experiencing a decline in its stock price, currently at 252.25, which reflects a decrease of 4.1 or 1.6%. The stock has underperformed its sector by 1.98% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 1.46%, and it has seen a significant drop of 8.94% over the past month. Year-to-date, the stock is down 15.89%, contrasting sharply with a 3.56% gain in the Sensex. Although there has been a notable increase in investor participation, with delivery volume rising by 337.5% against the 5-day average, the overall performance remains negative, and there are no positive or negative dashboard insights available to further clarify the stock's recent movement.
In the broader market context, Infinium Pharmachem's short-term performance has been weaker than the benchmark, as indicated by its 1-week return of -1.46% compared to the Sensex's -0.67%. This underperformance is further highlighted by the stark contrast in year-to-date returns, where the stock has declined significantly while the Sensex has gained. The liquidity of the stock appears adequate for trading, but the overall negative trends in both short-term and longer-term performance suggest that market sentiment may be unfavorable towards Infinium Pharmachem at this time.